Posted 3rd April 2023
Posted 2 years ago
By GS Verde Group
SolasCure announces £10.9m Series B fundraise to advance wound care innovation
Biotech company SolasCure, has announced completion of its Series B investment round, supporting development of its first investigational product, a hydrogel aiming to accelerate wound debridement.